Annual report

Period2025-01-01 → 2025-12-31
Filed2026-03-26
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 149
MetricValuePeriodScopeSource row
Revenue¥2.47T2025-01-01 → 2025-12-31Cons.Revenue IFRS
Revenue¥2.33T2024-01-01 → 2024-12-31Cons.Revenue IFRS
Revenue¥2.02T2023-01-01 → 2023-12-31vCons.Revenue IFRS (5-year summary)
Revenue¥1.74T2022-01-01 → 2022-12-31vCons.Revenue IFRS (5-year summary)
Revenue¥1.50T2021-01-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥479.4bn2025-01-01 → 2025-12-31Cons.Operating profit loss IFRS
Operating income¥323.6bn2024-01-01 → 2024-12-31Cons.Operating profit loss IFRS
Profit before tax¥468.0bn2025-01-01 → 2025-12-31Cons.Profit loss before tax IFRS
Profit before tax¥335.9bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS
Profit before tax¥142.7bn2023-01-01 → 2023-12-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥173.0bn2022-01-01 → 2022-12-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥163.6bn2021-01-01 → 2021-12-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥363.1bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥343.1bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥121.6bn2023-01-01 → 2023-12-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥133.9bn2022-01-01 → 2022-12-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥125.5bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥366.2bn2025-01-01 → 2025-12-31Cons.Profit loss IFRS
Net income¥347.3bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS
Total assets¥4.20Tat 2025-12-31Cons.Assets IFRS
Total assets¥3.74Tat 2024-12-31Cons.Assets IFRS
Total assets¥3.36Tat 2023-12-31vCons.Total assets IFRS (5-year summary)
Total assets¥3.10Tat 2022-12-31vCons.Total assets IFRS (5-year summary)
Total assets¥2.82Tat 2021-12-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥1.10Tat 2025-12-31Cons.Liabilities IFRS
Total liabilities¥961.1bnat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥3.10Tat 2025-12-31Cons.Equity IFRS
Net assets / equity¥2.78Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥2.44Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥3.03Tat 2025-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.73Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.39Tat 2023-12-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥2.23Tat 2022-12-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥2.01Tat 2021-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥534.6bnat 2025-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥426.2bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥513.3bnat 2023-12-31vCons.Cash and cash equivalents IFRS
Cash & equivalents¥471.6bnat 2022-12-31vCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥410.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥403.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥354.6bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥283.2bn2023-01-01 → 2023-12-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥211.8bn2022-01-01 → 2022-12-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥228.9bn2021-01-01 → 2021-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥161.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥265.8bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥190.5bn2023-01-01 → 2023-12-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥81.6bn2022-01-01 → 2022-12-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥95.3bn2021-01-01 → 2021-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥137.3bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥189.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.3bn2023-01-01 → 2023-12-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥95.5bn2022-01-01 → 2022-12-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥95.8bn2021-01-01 → 2021-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥685.062025-01-01 → 2025-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥633.762024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥224.12023-01-01 → 2023-12-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥246.82022-01-01 → 2022-12-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥231.322021-01-01 → 2021-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥246.782022-01-01 → 2022-12-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥231.152021-01-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥5,743.73at 2025-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥5,089.58at 2024-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,410.8at 2023-12-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,100.84at 2022-12-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,707.64at 2021-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio72.3%at 2025-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.1%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.2%at 2023-12-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.7%at 2022-12-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.3%at 2021-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE12.6%2025-01-01 → 2025-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE13.4%2024-01-01 → 2024-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE5.3%2023-01-01 → 2023-12-31vCons.Rate of return on equity IFRS (5-year summary)
ROE6.3%2022-01-01 → 2022-12-31vCons.Rate of return on equity IFRS (5-year summary)
ROE6.5%2021-01-01 → 2021-12-31dCons.Rate of return on equity IFRS (5-year summary)
Employees37,758at 2025-12-31Cons.Number of employees
Employees35,338at 2024-12-31Cons.Number of employees
Employees34,388at 2023-12-31vCons.Number of employees
Employees33,482at 2022-12-31vCons.Number of employees
Employees33,226at 2021-12-31dCons.Number of employees
Revenue¥98.8bn2025-01-01 → 2025-12-31StandaloneOperating revenue1
Revenue¥118.0bn2024-01-01 → 2024-12-31StandaloneOperating revenue1
Revenue¥82.4bn2023-01-01 → 2023-12-31vStandaloneOperating revenue1 (5-year summary)
Revenue¥57.0bn2022-01-01 → 2022-12-31vStandaloneOperating revenue1 (5-year summary)
Revenue¥115.0bn2021-01-01 → 2021-12-31dStandaloneOperating revenue1 (5-year summary)
Operating income¥82.7bn2025-01-01 → 2025-12-31StandaloneOperating income
Operating income¥102.9bn2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income¥84.2bn2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income¥105.0bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income¥70.0bn2023-01-01 → 2023-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥46.4bn2022-01-01 → 2022-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥104.8bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥88.4bn2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax¥105.0bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income¥89.9bn2025-01-01 → 2025-12-31StandaloneProfit loss
Net income¥106.4bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income¥71.0bn2023-01-01 → 2023-12-31vStandaloneNet income loss (5-year summary)
Net income¥47.4bn2022-01-01 → 2022-12-31vStandaloneNet income loss (5-year summary)
Net income¥106.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.32Tat 2025-12-31StandaloneAssets
Total assets¥1.38Tat 2024-12-31StandaloneAssets
Total assets¥1.21Tat 2023-12-31vStandaloneTotal assets (5-year summary)
Total assets¥1.27Tat 2022-12-31vStandaloneTotal assets (5-year summary)
Total assets¥1.25Tat 2021-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥298.8bnat 2025-12-31StandaloneLiabilities
Total liabilities¥309.6bnat 2024-12-31StandaloneLiabilities
Net assets / equity¥1.03Tat 2025-12-31StandaloneNet assets
Net assets / equity¥1.07Tat 2024-12-31StandaloneNet assets
Net assets / equity¥1.08Tat 2023-12-31vStandaloneNet assets
Net assets / equity¥1.06Tat 2022-12-31vStandaloneNet assets (5-year summary)
Net assets / equity¥1.07Tat 2021-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥101.5bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥130.4bnat 2024-12-31StandaloneCash and deposits
EPS (basic)¥169.522025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥196.522024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥130.922023-01-01 → 2023-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥87.372022-01-01 → 2022-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥195.52021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥1402025-01-01 → 2025-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1202024-01-01 → 2024-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1102023-01-01 → 2023-12-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1002021-01-01 → 2021-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,941.14at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,997.67at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,989.83at 2023-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥1,959.51at 2022-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥1,970.44at 2021-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio77.4%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.6%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.1%at 2023-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2022-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio85.6%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE8.6%2025-01-01 → 2025-12-31StandaloneRate of return on equity (5-year summary)
ROE9.9%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE6.6%2023-01-01 → 2023-12-31vStandaloneRate of return on equity (5-year summary)
ROE4.4%2022-01-01 → 2022-12-31vStandaloneRate of return on equity (5-year summary)
ROE10.2%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued542,988,917at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued552,024,717at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued557,835,617at 2023-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued557,835,617at 2022-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued557,835,617at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees224at 2025-12-31StandaloneNumber of employees
Employees183at 2024-12-31StandaloneNumber of employees
Employees151at 2023-12-31vStandaloneNumber of employees
Employees147at 2022-12-31vStandaloneNumber of employees
Employees137at 2021-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 61
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2025-01-01 → 2025-12-31¥9.0bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-12-31−¥3.6bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-12-31−¥3.6bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-12-31−¥56.8bn
Consumer Productsreportable segmentcapex2025-01-01 → 2025-12-31¥5.1bn
Consumer Productsreportable segmentemployeesat 2025-12-31590 pure
Consumer Productsreportable segmentrevenue2025-01-01 → 2025-12-31¥34.6bn
Consumer Productsreportable segmentrevenue external2025-01-01 → 2025-12-31¥34.6bn
Consumer Productsreportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥24m
Consumer Productsreportable segmentsegment profit2025-01-01 → 2025-12-31¥25.1bn
Nutraceuticalsreportable segmentcapex2025-01-01 → 2025-12-31¥38.9bn
Nutraceuticalsreportable segmentemployeesat 2025-12-319625 pure
Nutraceuticalsreportable segmentrevenue2025-01-01 → 2025-12-31¥577.7bn
Nutraceuticalsreportable segmentrevenue external2025-01-01 → 2025-12-31¥577.6bn
Nutraceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥48m
Nutraceuticalsreportable segmentsegment profit2025-01-01 → 2025-12-31¥57.7bn
Otherreportable segmentcapex2025-01-01 → 2025-12-31¥17.6bn
Otherreportable segmentemployeesat 2025-12-313143 pure
Otherreportable segmentrevenue2025-01-01 → 2025-12-31¥115.9bn
Otherreportable segmentrevenue external2025-01-01 → 2025-12-31¥112.4bn
Otherreportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥3.5bn
Otherreportable segmentsegment profit2025-01-01 → 2025-12-31¥8.0bn
Pharmaceuticalsreportable segmentcapex2025-01-01 → 2025-12-31¥221.7bn
Pharmaceuticalsreportable segmentemployeesat 2025-12-3122897 pure
Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-12-31¥1.74T
Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-12-31¥1.74T
Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-12-31¥445.3bn
—segment totalcapex2025-01-01 → 2025-12-31¥283.3bn
—segment totalemployeesat 2025-12-3136255 pure
—segment totalrevenue2025-01-01 → 2025-12-31¥2.47T
—segment totalrevenue external2025-01-01 → 2025-12-31¥2.47T
—segment totalrevenue intersegment2025-01-01 → 2025-12-31¥3.6bn
—segment totalsegment profit2025-01-01 → 2025-12-31¥536.2bn
Reconciling Itemsreconcilingcapex2024-01-01 → 2024-12-31¥9.9bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-12-31−¥3.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-12-31−¥3.6bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-12-31−¥51.8bn
Consumer Productsreportable segmentcapex2024-01-01 → 2024-12-31¥3.6bn
Consumer Productsreportable segmentrevenue2024-01-01 → 2024-12-31¥33.8bn
Consumer Productsreportable segmentrevenue external2024-01-01 → 2024-12-31¥33.8bn
Consumer Productsreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥7m
Consumer Productsreportable segmentsegment profit2024-01-01 → 2024-12-31¥23.0bn
Nutraceuticalsreportable segmentcapex2024-01-01 → 2024-12-31¥54.2bn
Nutraceuticalsreportable segmentrevenue2024-01-01 → 2024-12-31¥557.0bn
Nutraceuticalsreportable segmentrevenue external2024-01-01 → 2024-12-31¥557.0bn
Nutraceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥37m
Nutraceuticalsreportable segmentsegment profit2024-01-01 → 2024-12-31¥59.8bn
Otherreportable segmentcapex2024-01-01 → 2024-12-31¥7.7bn
Otherreportable segmentrevenue2024-01-01 → 2024-12-31¥113.7bn
Otherreportable segmentrevenue external2024-01-01 → 2024-12-31¥110.1bn
Otherreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥3.6bn
Otherreportable segmentsegment profit2024-01-01 → 2024-12-31¥7.5bn
Pharmaceuticalsreportable segmentcapex2024-01-01 → 2024-12-31¥252.0bn
Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-12-31¥1.63T
Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-12-31¥1.63T
Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-12-31¥285.1bn
—segment totalcapex2024-01-01 → 2024-12-31¥317.4bn
—segment totalrevenue2024-01-01 → 2024-12-31¥2.33T
—segment totalrevenue external2024-01-01 → 2024-12-31¥2.33T
—segment totalrevenue intersegment2024-01-01 → 2024-12-31¥3.6bn
—segment totalsegment profit2024-01-01 → 2024-12-31¥375.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 2,288
ItemContextValueUnit
Inventories ca IFRSCurrentYearInstant374323000000JPY
Buildings and structures acquisition cost IFRSPrior1YearInstant659452000000JPY
Machinery and vehicles acquisition cost IFRSPrior1YearInstant561553000000JPY
Tools furniture and fixtures acquisition cost IFRSPrior1YearInstant142198000000JPY
Land acquisition cost IFRSPrior1YearInstant100693000000JPY
Construction in progress acquisition cost IFRSPrior1YearInstant91824000000JPY
Property plant and equipment acquisition cost IFRSPrior1YearInstant1555721000000JPY
Buildings and structures acquisition cost IFRSCurrentYearInstant724914000000JPY
Machinery and vehicles acquisition cost IFRSCurrentYearInstant606153000000JPY
Tools furniture and fixtures acquisition cost IFRSCurrentYearInstant149856000000JPY
Land acquisition cost IFRSCurrentYearInstant116846000000JPY
Construction in progress acquisition cost IFRSCurrentYearInstant70892000000JPY
Property plant and equipment acquisition cost IFRSCurrentYearInstant1668663000000JPY
Buildings and structures accumulated depreciation and impairment losses IFRSPrior1YearInstant-387679000000JPY
Machinery and vehicles accumulated depreciation and impairment losses IFRSPrior1YearInstant-412394000000JPY
Tools furniture and fixtures accumulated depreciation and impairment losses IFRSPrior1YearInstant-114977000000JPY
Land accumulated impairment losses IFRSPrior1YearInstant-8854000000JPY
Construction in progress accumulated impairment losses IFRSPrior1YearInstant-3271000000JPY
Property plant and equipment accumulated depreciation and impairment losses IFRSPrior1YearInstant-927177000000JPY
Buildings and structures accumulated depreciation and impairment losses IFRSCurrentYearInstant-409875000000JPY
Machinery and vehicles accumulated depreciation and impairment losses IFRSCurrentYearInstant-429749000000JPY
Tools furniture and fixtures accumulated depreciation and impairment losses IFRSCurrentYearInstant-119883000000JPY
Land accumulated impairment losses IFRSCurrentYearInstant-8885000000JPY
Construction in progress accumulated impairment losses IFRSCurrentYearInstant-3461000000JPY
Property plant and equipment accumulated depreciation and impairment losses IFRSCurrentYearInstant-971855000000JPY
Buildings and structures IFRSPrior1YearInstant271772000000JPY
Machinery and vehicles IFRSPrior1YearInstant149159000000JPY
Tools furniture and fixtures IFRSPrior1YearInstant27220000000JPY
Land IFRSPrior1YearInstant91838000000JPY
Construction in progress IFRSPrior1YearInstant88553000000JPY
Property plant and equipment IFRSPrior1YearInstant628544000000JPY
Buildings and structures IFRSCurrentYearInstant315038000000JPY
Machinery and vehicles IFRSCurrentYearInstant176403000000JPY
Tools furniture and fixtures IFRSCurrentYearInstant29973000000JPY
Land IFRSCurrentYearInstant107961000000JPY
Construction in progress IFRSCurrentYearInstant67430000000JPY
Property plant and equipment IFRSCurrentYearInstant696808000000JPY
Goodwill acquisition cost IFRSPrior1YearInstant473189000000JPY
In process research and development acquisition cost IFRSPrior1YearInstant335915000000JPY
Trademarks and commercialization rights acquisition cost IFRSPrior1YearInstant445279000000JPY
Software acquisition cost IFRSPrior1YearInstant87996000000JPY
Other components of intangible assets acquisition cost IFRSPrior1YearInstant72409000000JPY
Intangible assets acquisition cost IFRSPrior1YearInstant941601000000JPY
Goodwill acquisition cost IFRSCurrentYearInstant534396000000JPY
In process research and development acquisition cost IFRSCurrentYearInstant336226000000JPY
Trademarks and commercialization rights acquisition cost IFRSCurrentYearInstant484927000000JPY
Software acquisition cost IFRSCurrentYearInstant88658000000JPY
Other components of intangible assets acquisition cost IFRSCurrentYearInstant103971000000JPY
Intangible assets acquisition cost IFRSCurrentYearInstant1013783000000JPY
Goodwill accumulated impairment losses IFRSPrior1YearInstant-23725000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identityconsolidated 2025-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass